Characterization of street rabies virus variants with an additional N-glycan at position 247 in the glycoprotein

被引:16
作者
Yamada, Kentaro [1 ]
Noguchi, Kazuko [1 ,2 ]
Nishizono, Akira [1 ,2 ]
机构
[1] Oita Univ, Res Promot Inst, Yufu, Oita 8795593, Japan
[2] Oita Univ, Fac Med, Dept Microbiol, Yufu, Oita 8795593, Japan
关键词
BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; ADULT MICE; NEUTRALIZING ANTIBODY; PERMEABILITY CHANGES; VIRAL GLYCOPROTEIN; MATRIX PROTEIN; AMINO-ACIDS; CLONED CDNA; PATHOGENICITY;
D O I
10.1007/s00705-013-1805-5
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Most street rabies virus glycoproteins (G proteins) possess two N-glycosylation sites, at Asn(37) and Asn(319), whereas an additional N-glycosylation site is present in several fixed (laboratory-adapted) rabies virus strains at Asn(247), which suggests that the N-glycosylation addition may be a marker of fixed viruses. In this study, we successfully cloned two street virus strain 1088 variants, N5B#15 and N5B#10-28, in which the G proteins had an additional N-glycan at position 247, and we examined whether these variants were characterized by cell culture adaptation and attenuation after intramuscular inoculation as fixed viruses. N5B#15 had four mutations, i.e., S148P and D247N in the G protein, and T137A and N2046S in the large (L) protein. N5B#10-28 had an additional mutation in the G protein, R196I. Compared with the parental 1088 virus, both variants exhibited highly efficient replication in mouse neuroblastoma-derived NA cells and reduced pathogenicity in adult mice when inoculated intramuscularly, but not intracerebrally. However, this attenuation was not attributable to the induction of strong immune responses.
引用
收藏
页码:207 / 216
页数:10
相关论文
共 38 条
[1]  
[Anonymous], 1979, JAPAN J TROP MED HYG
[2]   DIFFERENCES IN CELL-TO-CELL SPREAD OF PATHOGENIC AND APATHOGENIC RABIES VIRUS INVIVO AND INVITRO [J].
DIETZSCHOLD, B ;
WIKTOR, TJ ;
TROJANOWSKI, JQ ;
MACFARLAN, RI ;
WUNNER, WH ;
TORRESANJEL, MJ ;
KOPROWSKI, H .
JOURNAL OF VIROLOGY, 1985, 56 (01) :12-18
[3]   CHARACTERIZATION OF AN ANTIGENIC DETERMINANT OF THE GLYCOPROTEIN THAT CORRELATES WITH PATHOGENICITY OF RABIES VIRUS [J].
DIETZSCHOLD, B ;
WUNNER, WH ;
WIKTOR, TJ ;
LOPES, AD ;
LAFON, M ;
SMITH, CL ;
KOPROWSKI, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (01) :70-74
[4]   Spread and pathogenic characteristics of a G-deficient rabies virus recombinant:: an in vitro and in vivo study [J].
Etessami, R ;
Conzelmann, KK ;
Fadai-Ghotbi, B ;
Natelson, B ;
Tsiang, H ;
Ceccaldi, PE .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :2147-2153
[5]   A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity [J].
Faber, M ;
Faber, ML ;
Papaneri, A ;
Bette, M ;
Weihe, E ;
Dietzschold, B ;
Schnell, MJ .
JOURNAL OF VIROLOGY, 2005, 79 (22) :14141-14148
[6]   Identification of viral genomic elements responsible for rabies virus neuroinvasiveness [J].
Faber, M ;
Pulmanausahakul, R ;
Nagao, K ;
Prosniak, M ;
Rice, AB ;
Koprowski, H ;
Schnell, MJ ;
Dietzschold, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (46) :16328-16332
[7]   Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity [J].
Fabis, Marzena J. ;
Phares, Timothy W. ;
Kean, Rhonda B. ;
Koprowski, Hilary ;
Hooper, D. Craig .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (40) :15511-15516
[8]   MAPPING OF THE ANTIGENIC DETERMINANTS RECOGNIZED BY MONOCLONAL-ANTIBODIES AGAINST THE M2 PROTEIN OF RABIES VIRUS [J].
HIRAMATSU, K ;
MIFUNE, K ;
MANNEN, K ;
NISHIZONO, A ;
KAWANO, H ;
ITO, Y ;
KAWAI, A .
VIROLOGY, 1992, 187 (02) :472-479
[9]   The Production of Antibody by Invading B Cells Is Required for the Clearance of Rabies Virus from the Central Nervous System [J].
Hooper, D. Craig ;
Phares, Timothy W. ;
Fabis, Marzena J. ;
Roy, Anirban .
PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (10)
[10]   Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system [J].
Ito, N ;
Takayama-Ito, M ;
Yamada, K ;
Hosokawa, J ;
Sugiyama, M ;
Minamoto, N .
MICROBIOLOGY AND IMMUNOLOGY, 2003, 47 (08) :613-617